Download presentation
Presentation is loading. Please wait.
Published byLaura Webb Modified over 6 years ago
1
CASE 2 53 yo man HIV CD4 340/16% (Nadir) VL 30,100 c/ml
2
CASE 2 BASELINE GENOTYPE OCT/06
3
CASE 2 April 2008 Abacavir/3TC/Tenofovir/Ritonavir/ Lopinavir/Raltegravir/Maraviroc initiated as part of intensification study
4
CASE 2 REGIMEN HIV VIRAL LOAD 04/08 ABC/3TC/TNF/RTV/LPV/RGV/MVC 30,100
DATE REGIMEN HIV VIRAL LOAD 04/08 ABC/3TC/TNF/RTV/LPV/RGV/MVC 30,100 05/08 SAME AS ABOVE <50 01/09 SAME 01/10 01/11 <40 03/11 <0 (ultrasensitive)
5
CASE 2 March 2011 WHAT HAPPENED?
Regimen de-intensified to Truvada/Raltegravir as complex and VL=0 DATE REGIMEN HIV VIRAL LOAD 05/11 TDF/FTC/RGV 194 06/11 SAME AS ABOVE 175 07/11 SAME 361 09/11 244 WHAT HAPPENED?
6
CASE 2 GENOTYPE OCT/2011
7
CASE 2 WHAT WOULD YOU DO ?
8
CASE 2 Sept/2011 Told to stop all therapy x 3 months in order to repopulate with wild-type
9
CASE 2 Oct/2012-Jan/2012…No therapy CD4 460/17%, 330/17%
VL c/ml, c/ml
10
CASE 2 Jan/2012 Would you de-intensify?
Reinitiated ABC/3TC/RTV/DRV/ETR/RGV instead of ABC/3TC/TNF/RTV/LOP/RGV/MVC DATE CD4 COUNT HIV VIRAL LOAD 02/12 430/19% <40 03/12 04/12 600/16% 565/20% Would you de-intensify?
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.